Combined Periodontal-Endodontic Lesion Medical Services in China

Periodontal-endodontic combined lesions (PECL) represent a complex clinical condition where inflammation and infection simultaneously involve both the periodontal tissues (gingiva, periodontal ligament, alveolar bone) and the dental pulp. This bidirectional pathology arises either from primary endodontic infection spreading through apical foramina or lateralontium, or from advanced periodontitis compromising the apical seal and allowing bacterial ingress into the pulp. Clinical presentation includes deep periodontal pockets, persistent sinus tracts, tooth mobility, and often contradictory responses to pulp vitality testing—making diagnosis challenging without comprehensive radiographic assessment (e.g., cone-beam CT), periodontal probing, and differential diagnostic testing. Untreated PECL frequently leads to rapid bone loss, irreversible pulp necrosis, and eventual tooth loss. Management requires an integrated, interdisciplinary approach: precise root canal therapy combined with targeted periodontal debridement, regenerative procedures (e.g., guided tissue regeneration), and long-term maintenance.

China offers distinct advantages for treating PECL: world-class dental hospitals—especially in Beijing, Shanghai, and Guangzhou—feature state-of-the-art imaging systems, digital workflow integration, and multidisciplinary teams trained in both endodontics and periodontics. Chinese clinicians adhere strictly to international guidelines (AAE, EFP) while leveraging cost-effective access to premium biomaterials and minimally invasive techniques. Success rates exceed 85% over five years in tertiary centers, with documented cases showing complete periapical healing and pocket depth reduction from ≥7 mm to ≤3 mm post-treatment. Notably, Peking University School of Stomatology and Shanghai Ninth People’s Hospital have published longitudinal outcomes demonstrating superior regenerative outcomes using autologous platelet-rich fibrin and bioactive scaffolds.

Treatment Options & Itemized Cost Breakdown: Periodontic-Endodontic Lesion (牙周-牙髓联合病变)

Non-Surgical & Conservative Management

*Indicated for early-stage lesions with reversible pulpitis, minimal bone loss (<30%), and probing depths ≤5 mm.*

• •Comprehensive Diagnostic Workup: Clinical exam + CBCT (limited field) + periodontal charting + pulp vitality testing — $120–$180
• •Phase I Therapy (Scaling & Root Planing + Full-Mouth Disinfection): Per quadrant, includes ultrasonic + hand instrumentation, subgingival irrigation with 0.2% chlorhexidine — $1/quadrant
• •Empirical Antibiotic Regimen (7-day course): Amoxicillin 500 mg + Metronidazole 400 mg (BID) — $12–$20
• •Follow-up Re-evaluation (6 weeks): Probing, mobility, radiographic assessment — $45–$65

Surgical & Interventional Procedures

*Required for advanced lesions: vertical bone defects ≥4 mm, furcation involvement (Grade II/III), or persistent sinus tract after non-surgical therapy.*

• •Preoperative Workup: Full-mouth CBCT (16–24 teeth), blood coagulation panel, HbA1c (if diabetic), ECG (≥60 years) — $210–$320
• •Combined Therapy Protocol:

- *Open Flap Debridement + Osseous Reshaping* (per tooth, including bone graft if indicated) — $450–$780/tooth - *Guided Tissue Regeneration (GTR)*: Collagen membrane + deproteinized bovine bone mineral (DBBM) — $890–$1,350/tooth

• •Laser-Assisted Periodontal Therapy (Er:YAG): Adjunctive to flap surgery, reduces bacterial load — +$190–$310/tooth

Special & Complex Condition Management

• •Teeth with Grade III Furcation + Vertical Defects + Mobility Class II: Requires regenerative surgery + splinting (fiber-reinforced composite) — $1,420–$2,180/tooth
• •Systemically Compromised Patients (uncontrolled diabetes, anticoagulated): Extended pre-op workup + perioperative antibiotic prophylaxis (IV ceftriaxone) — +$320–$560
• •Failed Regeneration Cases Requiring Extraction + Immediate Implant Placement: Includes socket preservation, implant (domestic brand), abutment — $2,650–$4,100/tooth

Quick Selection Guide

• •Young Adult (<40), Mild-Moderate Lesion, Budget-Conscious: Phase I therapy + RCT → Total $450–$800
• •Middle-Aged (40–65), Moderate-Severe Bone Loss, No Comorbidities: Flap surgery + RCT + GTR → Total $1,600–$2,400/tooth
• •Elderly (≥65), Uncontrolled Diabetes/Hypertension, Severe Mobility: Pre-op optimization + conservative RCT + stabilization splint → Total $1,1,750/tooth
• •High-Risk Anatomic Complexity (e.g., mandibular molar with thin buccal plate + apical bifurcation): CBCT-guided microsurgical RCT + GTR → Total $2,200–$3,300/tooth